FIELD: medicine, pharmaceutics.
SUBSTANCE: in formula (I) R represents C6-10aryl substituted by one or more substitutes independently specified in R3; or R represents (C3-C9)-cycloalkyl or (C6)-cycloalkenyl each of which may be optionally substituted by one or more substitutes optionally specified in R4; R3 represents halogen, hydroxyl; or R3 represents (C1-C4)-alkyl, (C6)-aryl or R3 represents -NRaCORb, -ORa or -NRdRe; R4 represents cyano; or R4 represents (C1-C4)-alkyl, or R4 represents -COORc; Ra and Rb independently represent hydrogen, (C1-C4)-alkyl, (C2-C4)-alkenyl, (C6)-aryl; Rc represents (C1-C4)-alkyl, Rd and Re independently represent hydrogen, (C1-C4)-alkyl, (C6)aryl, (C6)aryl(C1-C4)-alkyl. The invention also refers to a pharmaceutical composition containing the above compound.
EFFECT: invention refers to the compound of structural formula I, which can be used to prevent, treat or reduce an intensity of symptoms of a disease or condition susceptible to IL-8 keratinocyte release stimulation, susceptible to neutrophil oxidative burst stimulation or susceptible to necrosis induction.
26 cl, 345 ex
Title | Year | Author | Number |
---|---|---|---|
INGENOL-3-ACYLATES III AND INGENOL-3-CARBAMATES | 2011 |
|
RU2572549C2 |
INGENOL-3-ACYLATES I | 2011 |
|
RU2575349C2 |
METHOD OF PRODUCING INGENOL-3-ANGELATE | 2011 |
|
RU2586975C2 |
HETEROCYCLIC COMPOUNDS HAVING AFFINITY TO MUSCARINE RECEPTORS | 2008 |
|
RU2446166C2 |
CONDENSED TRICYCLIC DERIVATIVES FOR TREATING PSYCHOTIC DISORDERS | 2005 |
|
RU2409582C2 |
1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHBITORS | 2007 |
|
RU2451015C2 |
PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2340611C2 |
DERIVATIVES OF 2-SUBSTITUTED PHENYL-5,7-DIHYDROCARBYL-3,7-DIHYDROPYRROLO[2,3-d]PYRIMIDIN-4-ONES, THEIR PREPARING AND PHARMACEUTICAL USING | 2004 |
|
RU2323220C2 |
CONDENSING DICYCLIC NITROGEN CONTAINING HETEROCYCLES, WHICH HAVE DGAT INHIBITING ACTION | 2003 |
|
RU2342388C2 |
QUINOLINE AND QUINAZOLINE DERIVATIVES WITH AFFINITY TO 5HT-RECEPTORS | 2004 |
|
RU2402533C2 |
Authors
Dates
2016-02-20—Published
2011-12-22—Filed